S&P 5007,691▲ 0.41%Nasdaq26,431▲ 1.11%Dow Jones51,966▼ 0.07%Nasdaq 10029,529▲ 1.17%VIX18.44▼ 7.75%US Dollar101.97▲ 0.13%Gold spot4,165▲ 0.21%WTI spot101.91▲ 1.04%
Home › ALBLD › Research report
← ALBLD page
XStocksXray
Market X-Ray report · 19 October 2026

Bilendi (ALBLD)

Euronext Paris · France · prices in EUR · close of 19 Oct 2026

Key indicators

Last closeEUR 7.600
52-week range7.040 – 21.500
Return, 1 month / 3 months−22.6% / −51.0%
Return, 1 year / 3 years−63.1% / −31.7%
TrendBelow its 200-day average
RSI (14)27
Volatility (1 year)42.5%
Worst drawdown (1 year)-66.1%
Average daily value traded0.06M EUR
Dividend yield–

Market X-Ray price-based

22/ 100 · High confidence · ahead of 10% of stocks on this exchange
Trend9
Momentum6
Stability (higher is calmer)30
Liquidity58
Income–

Five-year price chart navy: price · brown: 200-day average

5.7212.2118.7125.2031.692021-112023-022024-052025-072026-10

About the company

Bilendi is a market research company based in France that runs online panels and collects survey data for clients. It provides services to research agencies, brands and other organisations that need consumer and business feedback, using online questionnaires and panel management tools. The company also offers technology for managing panels and fieldwork, and it operates across several European countries, helping clients gather opinions and behaviour data from respondents.

On this site Bilendi appears as a stock on the Euronext Paris (France), code ALBLD, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Bilendi (ALBLD) trades on the Euronext Paris in France. It last closed at EUR 7.600 on 19 October 2026.

Its price-based Market X-Ray is 22 out of 100 (a weak price profile), ranking 563 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 63.1% and over the last three months it fell 51.0%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Bilendi (ALBLD)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend9 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-45.1%
From 52-week high-63.8%
Momentum6 · WeakLagging most stocks on this exchange.
3-month return-51.0%
6-month return-50.0%
12-month return, skipping the last month-52.3%
Stability (higher is calmer)30 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)42.5%
Worst drawdown, 1 year (smaller is calmer)-66.1%
Liquidity58 · FairModerate trading activity.
Average daily value traded0.06M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week−10.6%
1 month−22.6%
3 months−51.0%
6 months−50.0%
1 year−63.1%
3 years−31.7%
5 years−56.1%

Signals

50-day / 200-day average10.684 / 13.843
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.431

Technical summary

DailyStrongly bearish2 bullish · 2 neutral · 12 bearish
WeeklyStrongly bearish1 bullish · 0 neutral · 11 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 20 Oct 2026